Agile Therapeutics, Inc.
Q2 2023 13F Holders
Symbol
AGRX
CUSIP
00847L308
Type
Equity
Class
COM
Num filings
17
Total reported value, excl. options
$426 k
Compare 2023 Q2 to
2024 Q1
2023 Q4
2023 Q3
Manager
Report Date
Value ($000)
Shares
Option Type